European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-06-18

Assessment of the hazard and opportunities of using carbon nanotubes as a new nanocarrier for drug delivery in neural tissue

Cel

"While neurodegenerative disorders and brain cancers increase in the population, current therapies have shown their limits. But thanks to recent advancements in nanosciences and nanotechnologies, new therapeutic opportunities are offered based on the development of nanoscale drug delivery systems. Among those, carbon nanotubes (CNT) have shown promising applications for therapy of a broad range of diseases because of their highly tunable abilities to transport different molecules and to penetrate cells. In this multidisciplinary project, we propose to use chemically functionalised CNT (f-CNT) as drug delivery systems for brain disease. However, since the knowledge concerning the interaction of CNT and the brain parenchyma is poor, the main goals of the project will be to define: (i) the potential hazard of using f-CNT in the brain and (ii) the pharmaceutical opportunities that these nanocarrier systems could offer. Our overall objective will be to identify critical parameters for the design/engineering of safe and effective carbon nanotubes based drug nanovectors for brain disease, with a special focus on the CNT surface functionalization. We will use both in vitro and in vivo studies to adresses these different questions."

Zaproszenie do składania wniosków

FP7-PEOPLE-2010-IEF
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

UNIVERSITY COLLEGE LONDON
Wkład UE
€ 199 549,60
Adres
GOWER STREET
WC1E 6BT LONDON

Zobacz na mapie

Rodzaj działalności
Higher or Secondary Education Establishments
Kontakt administracyjny
Greta Borg-Carbott (Ms.)
Linki
Koszt całkowity
Brak danych

Uczestnicy (1)